Insulet Corporation to Present at Upcoming Investor Conferences

Insulet Corporation to Present at Upcoming Investor Conferences

ID: 291868

(firmenpresse) - BEDFORD, MA -- (Marketwired) -- 08/28/13 -- Insulet Corporation (NASDAQ: PODD), the leader in technology with its OmniPod® Insulin Management System, today announced the Company will participate in the following upcoming investor conferences:

The Morgan Stanley Global Healthcare Conference taking place at the Grand Hyatt in New York City. Management is scheduled to present an overview of the Company on Wednesday, September 11, 2013 at 8:00 a.m. ET.

The CL King's 11th Annual Best Ideas Conference taking place at the Omni Berkshire Place Hotel in New York City. Management is scheduled to present an overview of the Company on Wednesday, September 11, 2013 at 11:20 a.m. ET.

During these presentations, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to the audio webcast of these presentations during the event, please visit: . A replay of each webcast will be available for 10 days after the initial presentation.

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and fully-automated cannula insertion. Insulet's subsidiary, Neighborhood Diabetes, is a leading distributor for diabetes products and supplies, delivered through a high touch customer service model. To read inspiring stories of people with diabetes living their lives to the fullest with OmniPod, visit our customer blog, Suite D: . Founded in 2000, Insulet Corporation is based in Bedford, Mass. For more information, please visit: .



Stephanie Marks for Insulet Corporation

877-PODD-IR1 (877-763-3471)



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  neoClose From neoSurgical Recognized as a 2013 Innovation of the Year by the Society of Laparoendoscopic Surgeons Lombard Medical Technologies Half Yearly Report
Bereitgestellt von Benutzer: Marketwired
Datum: 28.08.2013 - 20:15 Uhr
Sprache: Deutsch
News-ID 291868
Anzahl Zeichen: 0

contact information:
Town:

BEDFORD, MA



Kategorie:

Medical Devices



Diese Pressemitteilung wurde bisher 310 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Insulet Corporation to Present at Upcoming Investor Conferences"
steht unter der journalistisch-redaktionellen Verantwortung von

Insulet Corporation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Insulet Announces Organizational Changes ...

BILLERICA, MA -- (Marketwired) -- 06/30/15 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced a series of organizational changes designed to continue it ...

Alle Meldungen von Insulet Corporation



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z